share_log
Breakings ·  May 22 20:01
NeuroBo Pharmaceuticals' Da-1241 in Combination With Semaglutide Improves Liver Fibrosis and Demonstrates Additive Hepatoprotective Effects in Pre-Clinical Mash Models Compared to Either Treatment, Alone
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment